(Q45723104)

15 December 2017

Expression of a fusogenic membrane glycoprotein by an oncolytic herpes simplex virus potentiates the viral antitumor effect (English)

1 reference

15 December 2017

1 reference

5

Malcolm K Brenner

1 reference

15 December 2017

Xinping Fu

1

1 reference

15 December 2017

Lihua Tao

2

1 reference

15 December 2017

Aiwu Jin

3

1 reference

15 December 2017

Richard Vile

4

1 reference

15 December 2017

Xiaoliu Zhang

6

1 reference

15 December 2017

1 June 2003

1 reference

15 December 2017

1 reference

15 December 2017

7

1 reference

15 December 2017

748-754

1 reference

15 December 2017

6

1 reference

Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant

15 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900092-3

7 January 2021

Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900092-3

7 January 2021

Treatment of human breast cancer in a brain metastatic model by G207, a replication-competent multimutated herpes simplex virus 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900092-3

7 January 2021

Local and systemic therapy of human prostate adenocarcinoma with the conditionally replicating herpes simplex virus vector G207.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900092-3

7 January 2021

Combined therapy with chemotherapeutic agents and herpes simplex virus type 1 ICP34.5 mutant (HSV-1716) in human non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900092-3

7 January 2021

Enhancement of gene therapy specificity for diffuse colon carcinoma liver metastases with recombinant herpes simplex virus

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900092-3

7 January 2021

Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900092-3

7 January 2021

Viral shedding and biodistribution of G207, a multimutated, conditionally replicating herpes simplex virus type 1, after intracerebral inoculation in aotus.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900092-3

7 January 2021

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900092-3

7 January 2021

Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900092-3

7 January 2021

Oncolytic virotherapy for cancer with the adenovirus dl1520 (Onyx-015): results of phase I and II trials

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900092-3

7 January 2021

Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900092-3

7 January 2021

Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900092-3

7 January 2021

A hyperfusogenic gibbon ape leukemia envelope glycoprotein: targeting of a cytotoxic gene by ligand display.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900092-3

7 January 2021

A lentiviral vector expressing a fusogenic glycoprotein for cancer gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900092-3

7 January 2021

Regulation of herpes simplex virus gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900092-3

7 January 2021

An enhanced packaging system for helper-dependent herpes simplex virus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900092-3

7 January 2021

Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900092-3

7 January 2021

Identification of novel herpes simplex virus replicative intermediates by field inversion gel electrophoresis: implications for viral DNA amplification strategies

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900092-3

7 January 2021

Requirement for cellular cyclin-dependent kinases in herpes simplex virus replication and transcription

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900092-3

7 January 2021

10.1016/S1525-0016(03)00092-3

Identifiers

DOI

1 reference

15 December 2017

1 reference